Mesenchymal stem cells (MSCs) are a major component of various forms of tissue
engineering. MSCs have self‐renewal and multidifferential potential. Osteogenic …

The possibility of using adipose tissue‐derived stromal cells (ATSC) as alternatives to bone
marrow‐derived stromal cells (BMSC) for bone repair has garnered interest due to the …

The first tissue engineering product, autologous chondrocytes implantation or
transplantation (ACI or ACT), has been available for over a decade. Recently, adult tissue …

Human adipose-derived stem cells (ASCs) have become an increasing interest to both stem
cell biologists and clinicians because of their potential to differentiate into adipogenic …

Several therapeutic approaches have been developed to address hyaline cartilage
regeneration, but to date, there is no universal procedure to promote the restoration of …

Adipose-derived stem cells (ASCs) are found in a location within the adipose tissue known
as the stem cell niche. The ASCs in the niche are maintained in the quiescent state, and …

Bone regeneration is a complex process that is influenced by tissue interactions,
inflammatory responses, and progenitor cells. Diseases, lifestyle, or multiple trauma can …

Adipose-derived stromal cells (ASCs) are now emerging as a good alternative to bone
marrow derived mesenchymal stromal cells (BM-MSC) for cellular therapy. Similarly to BM …

Current cell-based repair strategies have proven unsuccessful for treating cartilage defects
and osteoarthritic lesions, consequently advances in innovative therapeutics are required …

Injury to the articular cartilage occurs commonly in the general population and undergoes
minimal spontaneous healing. Traditional methods of cartilage repair provide no long-term …